| 产品详情 |
| Edit |   |
| Product Name | SU11274 |
| Description | Purity >95%. MET is a proto-oncogene which encodes the hepatocyte growth factor receptor c-Met. It has normal roles in morphogenesis, migration, apoptosis, and angiogenesis. Dysregulation of c-Met occurs in many types of cancer. SU11274 is a potent, selective, ATP-competitive inhibitor of c-Met (IC50 = 20 nM). It has much less or no activity against other receptor tyrosine kinases. SU11274 induces apoptosis and cell cycle arrest in transformed Ba/F3 cells and cancer cell lines. |
| Size | n/a |
| Concentration | n/a |
| Applications | n/a |
| Other Names | (3Z)-N-(3-chlorophenyl)-3-[[3,5-dimethyl-4-[(4-methyl-1-piperazinyl)carbonyl]-1H-pyrrol-2-yl]methylene]-2,3-dihydro-N-methyl-2-oxo-1H-indole-5-sulfonamide, Met Kinase Inhibitor |
| Gene, Accession, CAS # | CAS: 658084-23-2 |
| Catalog # | LS-H10056 |
| Price | |
| Order / More Info | SU11274 from LIFESPAN BIOSCIENCES INC. |
| Product Specific References | n/a |
| 产品资料 |
|
|